Protocol: Nef-301: A Randomzied, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary Iga Nephropathy at Risk Prgressing to End-Stage Renal Disease(NefIgArd)

Project: Research project

Project Details

StatusActive
Effective start/end date2/5/19 → 1/20/24

Funding

  • Medpace Clinical Research LLC (Protocol: Nef-301)
  • Calliditas Therapeutics AB (Protocol: Nef-301)